Capital Fund Management (CFM)
FLNA

Capital Fund Management (CFM)’s Filana Therapeutics FLNA Stock Holding History

Capital Fund Management (CFM)’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-159,000
Closed -$4.68M – 2230
2024
Q3 		$4.68M Buy
159,000
+60,078
+61% +$1.38M 0.01% 1050
2024
Q2 		$1.22M Buy
+98,922
New +$2.09M ﹤0.01% 1557
2024
Q1 		– Sell
-14,310
Closed -$322K – 2235
2023
Q4 		$322K Sell
14,310
-5,655
-28% -$119K ﹤0.01% 2044
2023
Q3 		$332K Buy
19,965
+1,265
+7% +$25.1K ﹤0.01% 1853
2023
Q2 		$459K Buy
+18,700
New +$450K ﹤0.01% 1578

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Capital Fund Management (CFM)'s FLNA Position: Q4 2024 in Review

Capital Fund Management (CFM) sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 159,000 shares — an estimated $4.68M sold.

Capital Fund Management (CFM) first reported a position in FLNA in Q2 2023 and held it in 5 quarters. The position peaked at $4.68M in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Capital Fund Management (CFM) reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 159,000 Filana Therapeutics shares in Q4 2024, an estimated $4.68M.
  • Capital Fund Management (CFM) first reported a position in Filana Therapeutics in Q2 2023 and held it in 5 quarters.
  • Capital Fund Management (CFM)'s Filana Therapeutics position peaked at $4.68M in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2024, filed 13 Feb 2025.